Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.31 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3319502 | 0.87 | NPC1 (0.34) | NPC1RAB9ASMN1; SMN2HSD17B10GRM4 | |
| SCHEMBL3319508 | 0.87 | NPC1 (0.34) | NPC1RAB9ASMN1; SMN2HSD17B10GRM4 | |
| SCHEMBL17141150 | 0.87 | NPC1 (0.34) | NPC1RAB9ASMN1; SMN2HSD17B10GRM4 | |
| SCHEMBL3313883 | 0.77 | NPC1 (0.33) | NPC1RAB9ASMN1; SMN2HSD17B10GRM4 | |
| SCHEMBL3313889 | 0.77 | NPC1 (0.33) | NPC1RAB9ASMN1; SMN2HSD17B10GRM4 | |
| SCHEMBL3319831 | 0.73 | ALDH1A1 (0.38) | NPC1RAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL3319836 | 0.73 | ALDH1A1 (0.38) | NPC1RAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL3316889 | 0.73 | THRA (0.34) | NPC1RAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL16116237 | 0.73 | ALDH1A1 (0.38) | NPC1RAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL3316894 | 0.73 | THRA (0.34) | NPC1RAB9ASMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3489232-A2 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | Syros Pharmaceuticals, Inc. (US) | 2019-05-29 | — | — | EP | disclosed |